Charles River Laboratories International (CRL) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Charles River Laboratories International (CRL) recorded Income from Non-Controlling Interests of $722,000 in Q2 2026, up 96.7% from $367,000 a year earlier.
Powered by 
Analysis
Charles River Laboratories International (CRL) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
On a TTM basis, Charles River Laboratories International's Income from Non-Controlling Interests came in at $2.16 million as of Jun 27, 2026, unchanged year-over-year; for FY2025, it was $2.18 million, down 29.6% from FY2024.
- Annual Income from Non-Controlling Interests has declined for four straight years, though with a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
- Across earlier years, Income from Non-Controlling Interests came in at $3.09 million in FY2024 (-46.3%), $5.75 million in FY2023 (-10.0%), $6.38 million in FY2022 (-18.8%) and $7.86 million in FY2021 (+683.9%).
- Quarterly Income from Non-Controlling Interests has ranged from $41,000 in Q1 2026 to $2.42 million in Q2 2023 over the past five years.
- On a year-over-year basis, Income from Non-Controlling Interests rose in four of the last eight quarters, with an average decline of 1.0%.
- Peak year-over-year performance for Income from Non-Controlling Interests in the last five years was growth of 125.1% in Q4 2021, against a decline of 92.6% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $41,000 (Q1 2026), $265,000 (Q4 2025) and $1.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.71 Bn | 35.96 Bn | 1.50 Bn | 2.00 Mn |
| 2 | Medpace Holdings | 18.26 Bn | 15.91 Bn | 223.89 Mn | - |
| 3 | Charles River Laboratories International | 16.16 Bn | 15.36 Bn | 357.87 Mn | 1.38 Mn |
| 4 | Icon | 16.06 Bn | 12.83 Bn | 491.83 Mn | - |
| 5 | Fortrea Holdings | 2.10 Bn | 1.39 Bn | 139.50 Mn | - |
| 6 | Ginkgo Bioworks Holdings | 699.49 Mn | -62.59 Mn | 18.44 Mn | - |
| 7 | Evotec SE | 601.99 Mn | -1.16 Bn | - | - |
| 8 | Champions Oncology | 66.71 Mn | 41.80 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 48.93 Mn | 12.59 Mn | 1.61 Mn | - |
| 10 | Natural Alternatives International | 6.57 Mn | -21.51 Mn | 1.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 26, 2026 | 1.38 Mn |
| Jun 27, 2026 | 722,000.00 |
| Mar 28, 2026 | 41,000.00 |
| Dec 27, 2025 | 265,000.00 |
| Sep 27, 2025 | 1.13 Mn |
| Jun 28, 2025 | 367,000.00 |
| Mar 29, 2025 | 409,000.00 |
| Dec 28, 2024 | 748,000.00 |
| Sep 28, 2024 | 638,000.00 |
| Jun 29, 2024 | 180,000.00 |
| Mar 30, 2024 | 1.52 Mn |
| Dec 30, 2023 | 1.87 Mn |
| Sep 30, 2023 | 632,000.00 |
| Jul 1, 2023 | 2.42 Mn |
| Apr 1, 2023 | 823,000.00 |
| Dec 31, 2022 | 1.70 Mn |
| Sep 24, 2022 | 1.14 Mn |
| Jun 25, 2022 | 1.34 Mn |
| Mar 26, 2022 | 2.20 Mn |
| Dec 25, 2021 | 2.25 Mn |
API Access
Charles River Laboratories International Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();